Formulating biopharmaceuticals is no simple task. In fact, it’s one of the most intricate and complex stages of modern drug development.
It’s a highly specialised process, one that involves far more than simply mixing ingredients. It’s about creating the right environment to protect delicate biomolecules throughout the manufacturing, storage and delivery stages.
Here, we’ll look at the core methods used in formulating biopharmaceuticals. This includes buffer selection and pH optimisation, advanced drying techniques and analytical testing. Each step in each of these processes is essential for developing safe and effective biologic medicines.
In this post:
Key Takeaways
Biopharmaceuticals are structurally sensitive, so formulation focuses on preventing degradation and preserving activity
Core tools include optimised buffers, stabilising excipients, and specialised drying methods like lyophilisation
Rigorous analytical testing and batch-to-batch consistency are essential for meeting regulatory standards
High-purity materials and reliable mixing processes play a critical role in overall product quality
Understanding the Fundamentals of Biopharmaceutical Formulation
First of all, it’s important to understand what biopharmaceuticals actually are. They’re large, complex molecules such as proteins, peptides, antibodies, RNA/DNA products, and viral vectors.
Unlike small-molecule drugs, these biologics simply can’t tolerate strong chemicals, heat, agitation, shifts in pH, or the freezing and thawing process.
This is why formulation methods need to be focused on keeping the molecules stable, active, and safe across the entire manufacturing process. To do this, formulation methods need to prevent issues such as:
- Protein denaturation – where the molecule essentially unfolds
- Aggregation – where materials clump together, which can be a major safety risk
- Chemical degradation – such as oxidation or hydrolysis
- Loss of potency over time
Key Challenges in Developing Biologic Formulations
Formulation scientists have a number of hurdles to overcome when developing biologic formulations. These include sensitivity to environment conditions, where even the slightest temperature change can cause proteins to unfold and other symptoms of instability.
There’s a need for ultrapure materials (such as ultrapure water, for example), as impurities can trigger aggregation. Lab conditions need to be carefully controlled, especially when it comes to temperature control.
There are lots of different ways that these molecules can degrade, so scientists need to ensure that absolutely all bases are covered.
Core Methods Used in Biopharmaceutical Formulation
Now, let’s move on to look at the core methods commonly used in biopharmaceutical formulation.
Buffer Selection and pH Optimisation
Biologics are very pH sensitive. This means that even slight deviations can cause problems with aggregation or unfolding.
Biological buffers are chemical systems which resist pH changes, and are therefore able to protect the biologic during both storage and use.
Common buffers used in formulation processes include phosphate, histidine, and citrate. They’re chosen based on the charge, solubility, and known degradation risks of the molecule in question.
Use of Excipients and Stabilising Agents
Excipients are the inactive ingredients in a medication. They’re there as stabilising agents, to protect the biologic through manufacturing and storage.
Examples of commonly used excipients include:
- Sugars such as sucrose and trehalose – which stabilise proteins during freezing or drying
- Amino acids such as arginine – which reduce aggregation
- Surfactants such as polysorbate 20/80 – which prevent surface-induced damage
- Antioxidants and chelators to limit chemical degradation
These must be precisely mixed to create a safe, stable, and effective final product.
Lyophilisation and Advanced Drying Techniques
Advanced drying techniques can be used to reduce molecular mobility. This helps biologics to stay stable for far longer.
The most common approach used in biopharmaceutical formulation is lyophilisation, which protects proteins during freezing.
This is essentially freeze-drying, a process involving removing water from a product by freezing it and then lowering the pressure. This last step allows the frozen water to turn directly into vapour.
Other advanced techniques, including controlled ice nucleation or spray drying, are also used.
Quality Control and Regulatory Considerations
In order to meet high quality control and regulatory requirements for medicines, the stability of biologics needs to be tested, analysed, and confirmed.
Consistency across batches is crucial, so the methods used need to be repeatable, reliable and industry-approved.
Analytical Testing and Validation Methods
A biologic’s stability can be confirmed using specialised analytical tools, including:
- Dynamic Light Scattering (DLS) for determining the aggregation state of molecules
- High-Performance Liquid Chromatography (HPLC) and mass spectrometry to test for chemical degradation
- Bioassays for potency
- Sterility and endotoxin tests for safety
High-purity chemicals and water are essential in many of these tests, to ensure accuracy and prevent interference.
Ensuring Consistency Across Batches and Scales
Regulatory frameworks require biologics to perform consistently from batch to batch.
This involves a carefully controlled product development process, including controlling raw materials, maintaining precise mixing conditions, and validating that scale-up does not introduce new stresses or degradation risks.
Conclusion
Formulating biopharmaceuticals requires precise methods that protect fragile molecules from degradation at every stage of development. Through the use of buffers, stabilisers, drying techniques, and quality control processes, manufacturers can ensure biologics remain safe, effective, and reliable.
